Connect with us

African News

Nigeria Receives First Batch Of Oxford-AstraZeneca Vaccines to help fight Convid-19

Published

on

Nigeria has received its first batch of COVID-19 vaccines.

The NAFDAC-approved Oxford-AstraZeneca vaccines arrived at the Nnamdi Azikiwe International Airport, Abuja, around noon on Tuesday, via an Emirates airline.

Chairman of the Presidential Task Force (PTF) on COVID-19, Boss Mustapha, had said on Saturday that Nigeria will receive its first tranche of about 4 million doses of the coronavirus vaccines.

On the ground to take delivery of the vaccines were top government officials including the PTF Chairman, Boss Mustapha; the Minister for Health, Osagie Ehanire; the Minister for Information, Lai Mohammed; and the Director-General of the Nigeria Centre for Disease Control (NCDC) Chikwe Ihekweazu.

Speaking last week, the Health Minister had noted that also noted that once the vaccines arrive in the country, about 70% of the population is expected to be inoculated within two years.

“We have been told to open an account with Afreximbank under the African Union; we have done that already successfully because we are going to pay for that part of the vaccine. The COVAX vaccine is free, at no cost to us, it is made from donations,” Mr Ehanire said.

“We want to immunise about 60 to 70% of our population. If COVAX immunises 20, then we have about 40 to 50 to immunise within the next two years. So, we have to pay for that minus any donations that we get like the MTN donation, for example, all those ones reduce the quantities that we have to purchase or any other that in future are given to us free of charge.

The minister made the comments on February 24, the same day that Ghana became the first country to receive vaccines from COVAX- a global scheme to procure and distribute Covid inoculations for free for poorer countries.

The 600,000 doses delivered to Ghana were the Oxford/AstraZeneca formula, made under license by the world’s largest vaccine manufacturer, the Serum Institute of India.